Pushing boundaries beyond current standards, future of pulmonology – research, innovation & unmet needs explores next-generation concepts that could redefine the field. From lung organoids and AI-derived drug discovery platforms to CRISPR-based correction of genetic lung disorders, early-phase breakthroughs are rapidly moving toward clinical application. Research is increasingly focused on identifying mechanistic pathways in rare and idiopathic respiratory diseases, such as pulmonary alveolar proteinosis and lymphangioleiomyomatosis. Future of Pulmonology – Research, Innovation & Unmet Needs brings attention to underfunded areas, including sex-specific disease expression, climate-lung interactions, and access to cutting-edge care in low-resource settings. Interdisciplinary research teams are leveraging nanomedicine, 4D imaging, and bioprinting technologies to overcome current limitations in diagnosis and treatment. The roadmap ahead demands sustained funding, ethical oversight, and inclusive innovation to ensure the field progresses equitably and impactfully.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation